Skip to main content
. 2022 Oct 21;113(3):643–659. doi: 10.1002/cpt.2749

Table 3.

CYP2D6 star allele frequencies across all sub‐Saharan African populations included in the study

Allele frequencies (%)
CYP2D6 allele CPIC function All (n = 947) FNB (n = 49) BRN (n = 49) BFA (n = 33) GHA (n = 26) CAM (n = 26) BSZ (n = 41) BOT (n = 47) SA (n = 153) ESN (n = 98) YRI (n = 107) GWD (n = 111) MSL (n = 84) LWK (n = 95)
*1 Normal 24.7 17.3 24.5 30.3 26.9 21.2 32.9 31.9 22.9 29.6 25.7 26.6 18.5 20.5
*2 Normal 13.4 9.2 15.3 13.6 13.5 21.2 12.2 11.7 13.7 9.2 11.2 14 14.3 18.4
*27 Normal 0.3 1 0 0 0 0 0 0 0 0 0 0 0 2.1
*34 Normal 0.1 0 0 0 0 0 0 0 0 0 0 0.5 0 0
*39 Normal 0.1 1 0 0 0 0 0 0 0 0 0 0 0 0
*45 Normal 3.7 4.1 3.1 4.5 7.7 3.8 3.7 2.1 4.9 4.6 3.3 1.8 3.6 3.7
*46 Normal 0.5 0 1 0 0 0 0 1.1 0 1 0 1.4 0 1.1
*17x2 Normal 0.2 1 0 1.5 0 0 0 0 0 0.5 0 0 0 0
*29x2 Normal 0.3 2 0 0 0 0 0 0 0 0 0 1.4 0 0.5
*10 Decreased 3.9 5.1 3.1 1.5 0 1.9 4.9 3.2 4.6 1.5 4.7 5.4 8.9 1.1
*17 Decreased 19.5 30.6 23.5 15.2 21.2 5.8 14.6 19.1 16.7 22.4 22.9 14.9 23.8 18.4
*29 Decreased 10.0 4.1 10.2 12.1 5.8 13.5 17.1 6.4 10.1 7.1 9.3 9.9 8.9 16.3
*41 Decreased 0.8 2 0 0 0 0 0 0 0.7 1.5 0.9 0.5 0.6 2.6
*84 Decreased 0.1 0 1 0 0 0 0 1.1 0 0 0 0 0 0
*4 No function 1.7 3.1 0 0 0 3.8 1.2 0 2.3 2.6 0.5 2.7 1.2 2.1
*5 No function 8.1 7.1 6.1 6.1 7.7 7.7 7.3 13.8 14.7 3.6 6.5 5 8.9 4.7
*12 No function 0.2 0 0 0 0 1.9 0 2.1 0 0 0 0 0 0
*15 No function 0.2 0 0 0 0 0 0 0 0 1 0.5 0 0 0
*36 No function 0.4 0 0 1.5 0 0 0 0 0 0 0 1.8 1.2 0
*40 No function 1.4 1 1 0 1.9 1.9 0 2.1 2.6 2.6 0.5 0.9 1.8 0
*42 No function 0.1 0 0 0 0 0 0 0 0 0 0 0.5 0 0.5
*56 No function 0.2 0 0 0 0 0 2.4 0 0 0 0 0 0.6 0
*69 No function 0.1 0 0 0 0 0 0 0 0.3 0 0 0 0 0
*68 + *4 No function 0.1 0 0 0 1.9 0 0 0 0 0 0 0 0 0
*13 No function 0.1 0 0 1.5 0 0 0 0 0 0 0 0 0 0
*4x2 No function 2.2 2 2 3 3.8 3.8 1.2 0 1.3 5.1 4.7 1.4 1.8 0.5
*4x3 No function 0.1 0 0 0 0 0 0 0 0 0 0.5 0 0.6 0
*1x2 Increased 0.4 0 1 0 3.8 0 0 1.1 0 0 0.5 1.4 0 0
*1x3 Increased 0.2 0 0 0 0 0 0 0 0.7 0 0.5 0 0 0
*2x2 Increased 1.9 2 3.1 3 0 1.9 0 3.2 0 5.1 2.8 2.3 1.2 1.1
*2x3 Increased 0.1 0 0 0 0 0 0 0 0 0 0 0 0.6 0
*2x4 Increased 0.1 2 1 0 0 0 0 0 0 0 0 0 0 0
*45x2 Increased 0.1 0 0 0 0 1.9 0 0 0 0 0 0 0 0.5
*45x3 Increased 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0.5
*43 Uncertain 0.8 0 2 1.5 1.9 0 0 0 0.3 0.5 0 1.8 0 3.2
*43x2 Uncertain 0.1 0 0 0 0 0 0 0 0 0 0.5 0 0 0
*73 Unknown 0.2 0 0 0 0 0 0 0 1 0 0 0 0 0
*74 Unknown 0.1 0 0 0 0 0 0 0 0.3 0 0 0 0 0
*106 Unknown 1.5 5.1 0 3 1.9 3.8 1.2 0 0.7 1 3.3 1.8 1.2 0
*122 Unknown 0.1 0 0 0 0 0 0 0 0 0 0 0.5 0 0
*125 Unknown 0.3 0 1 0 0 0 0 0 0 0.5 0.5 0.5 0 0.5
*139 Unknown 0.1 0 0 0 0 0 0 0 0 0.5 0 0 0 0
*149 Unknown 0.3 0 0 1.5 1.9 0 0 0 0 0 0 0.9 0.6 0

BFA, participants from Burkina Faso; BOT, participants from Botswana; BRN, Berom in Nigeria; BSZ, Bantu‐speakers in Zambia; CAM, Cameroonian participants; ESN, Esan in Nigeria; FNB, Fon in Benin; GHA, Ghanaian participants; GWD, Gambian in Western Division (Mandinka); LWK, Luhya in Webuye (Kenya); MSL, Mende in Sierra Leone; SA, South African participants; YRI, Yoruba in Ibadan, Nigeria.